PRPO (Precipio) 3-Year Dividend Growth Rate : 0.00% (As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Precipio 3-Year Dividend Growth Rate?

Precipio's Dividends per Share for the three months ended in Dec. 2024 was $0.00.

The historical rank and industry rank for Precipio's 3-Year Dividend Growth Rate or its related term are showing as below:

PRPO's 3-Year Dividend Growth Rate is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 6.5
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Precipio's Dividend Payout Ratio for the three months ended in Dec. 2024 was 0.00. As of today, Precipio's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Precipio's 3-Year Dividend Growth Rate

For the Diagnostics & Research subindustry, Precipio's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Precipio's 3-Year Dividend Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Precipio's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Precipio's 3-Year Dividend Growth Rate falls into.

Save Embed

;

Save Embed

;

Precipio 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Precipio (NAS:PRPO) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Precipio's Dividend Payout Ratio for the quarter that ended in Dec. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Dec. 2024 )	/	EPS without NRI (Q: Dec. 2024 )
	=	0	/	-0.24
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Precipio 3-Year Dividend Growth Rate Related Terms>

Precipio Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Precipio Inc (NAS:PRPO) » Definitions » 3-Year Dividend Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

4 Science Park, New Haven, CT, USA, 06511

Website

https://www.precipiodx.com

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

Executives

Ahmed Zaki Sabet	officer: Chief Operations Officer	33 ANDYS DR, EAST HAVEN CT 06512
Richard A Sandberg	director	330 NEVEDA STREET, NEWTON MA 02460-1458
Ilan Danieli	director, officer: Chief Executive Officer	14707 CALIFORNIA STREET, SUITE 5, OMAHA NE 68154
Matthew Gage	officer: Chief Financial Officer	56 STAGECOACH CIRCLE, MILFORD CT 06460
David Seth Cohen	director, 10 percent owner	C/O STANDARD OIL, 299 BISHOP AVENUE, BRIDGEPORT CT 06610
Ronald Asbury Andrews	director	5791 VAN ALLEN WAY, CARLSBAD CA 92008
Randal J Kirk	10 percent owner	1881 GROVE AVENUE, RADFORD VA 24141
Kathleen Laporte	director
Robert Patzig	director	THE GOVERNOR TYLER, 1881 GROVE AVENUE, RADFORD VA 24141
Michael A Luther	director	21 CORPORATE CIRCLE, ALBANY NY 12203
Jeffrey Cossman	director	C/O PRECIPIO INC., 4 SCIENCE PARK, NEW HAVEN CT 06511
Samuel D Riccitelli	director	2850 FRONTIER DR., WARSAW IN 46582
Carl Iberger	officer: Chief Financial Officer	C/O PRECIPIO, INC., 12325 EMMET STREET, OMAHA NE 68164
Douglas Fisher	director	587 PATROL RD, WOODSIDE CA 94062
Mark Rimer	director, 10 percent owner	C/O PRECIPIO, INC., 4 SCIENCE PARK, NEW HAVEN CT 06511